Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.37 |
| ▸ | GRM8 | O00222 | 1/20 | 0.37 |
| ▸ | GRM6 | O15303 | 1/20 | 0.37 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.37 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13497176 | 1.00 | USP2 (0.48) | USP2SLCO1B1SMN1; SMN2SLC22A6GABRR1 | |
| SCHEMBL31527767 | 1.00 | USP2 (0.48) | USP2SLCO1B1SMN1; SMN2SLC22A6GABRR1 | |
| SCHEMBL28410409 | 1.00 | USP2 (0.48) | USP2SLCO1B1SMN1; SMN2SLC22A6GABRR1 | |
| SCHEMBL300199 | 1.00 | USP2 (0.48) | USP2SLCO1B1SMN1; SMN2SLC22A6GABRR1 | |
| Ethane SCHEMBL10712982 | 0.95 | USP2 (0.45) | USP2SLCO1B1SMN1; SMN2SLC22A6GABRR1 | |
| SCHEMBL31154516 | 0.93 | SLC22A6 (0.59) | USP2SLCO1B1SMN1; SMN2SLC22A6GABRR1 | |
| SCHEMBL4713869 | 0.85 | USP2 (0.56) | USP2SLCO1B1SMN1; SMN2SLC22A6GABRR1 | |
| SCHEMBL4550634 | 0.82 | USP2 (0.52) | USP2SLCO1B1SMN1; SMN2SLC7A5MEN1 | |
| SCHEMBL2273519 | 0.82 | USP2 (0.46) | USP2SLCO1B1SMN1; SMN2SLC7A5MEN1 | |
| SCHEMBL2273513 | 0.82 | USP2 (0.46) | USP2SLCO1B1SMN1; SMN2SLC7A5MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 735 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4658249-A1 | COMPOSITIONS AND METHODS | BioNTech SE (DE) | 2025-12-10 | — | — | EP | claimed |
| US-12378328-B2 | Biohybrid peptidoglycan oligomers | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2025-08-05 | — | — | US | claimed |
| CN-118995783-A | Gene recombination engineering strain with malonyl coenzyme A synthesis path using L-glutamic acid as substrate and application thereof | 广东以色列理工学院 | 2024-11-22 | — | — | CN | claimed |
| WO-2024160828-A1 | COMPOSITIONS AND METHODS | BioNTech SE (DE) | 2024-08-08 | — | — | WO | claimed |
| CN-117431751-A | Pretreatment method for dyeing cotton textiles | 康赛妮集团有限公司 | 2024-01-23 | — | — | CN | claimed |
| CN-117106189-A | Metal organic framework artificial hydrolase and preparation method and application thereof | 华南理工大学 | 2023-11-24 | — | — | CN | claimed |
| CN-116430049-A | Metabolic marker of esophagus cancer and application thereof | 汕头大学医学院 | 2023-07-14 | — | — | CN | claimed |
| CN-109988312-B | Polyamide acid ester, preparation method, negative polyimide composition and application | 深圳先进技术研究院 | 2023-04-11 | — | — | CN | claimed |
| US-20220213232-A1 | BIOHYBRID PEPTIDOGLYCAN OLIGOMERS | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2022-07-07 | — | — | US | claimed |
| CN-112794806-A | Manufacturing process of functional cotton fabric | 王晨绚 | 2021-05-14 | — | — | CN | claimed |
| US-6472201-B1 | GROWING AND TESTING MICROORGANISMS IN A MULTITEST FORMAT WHICH UTILIZES A GEL FORMING MATRIX FOR THE RAPID SCREENING OF CLINICAL AND ENVIRONMENTAL CULTURES | BIOLOG, INC. | 2002-10-29 | — | — | US | claimed |
| WO-2001094327-A1 | CATALYST COMPRISING SOLUBLE POLYMER AND POLYAMINO ACID | STYLACATS LIMITED (GB) | 2001-12-13 | — | — | WO | claimed |
| US-5756650-A | COMPOSITION COMPRISING POLYAMIC ACID, CURE ACCELERATOR SELECTED FROM GROUP CONSISTING OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AMINO ACID COMPOUND, AROMATIC COMPOUND HAVING TWO OR MORE HYDROXYL GROUPS | KABUSHIKI KAISHA TOSHIBA (JP) | 1998-05-26 | — | — | US | claimed |
| EP-0513068-B1 | THREE NEW NON-POLYGLUTAMATABLE DEAZAAMINOPTERINS AND PROCESS FOR PREPARING THE SAME | NAIR MADHAVAN G (US) | 1995-09-13 | — | — | EP | claimed |
| EP-0513068-A1 | THREE NEW NON-POLYGLUTAMATABLE DEAZAAMINOPTERINS AND PROCESS FOR PREPARING THE SAME. | NAIR MADHAVAN G (US) | 1992-11-19 | — | — | EP | claimed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | claimed |
| WO-1991010666-A1 | THREE NEW NON-POLYGLUTAMATABLE DEAZAAMINOPTERINS AND PROCESS FOR PREPARING THE SAME | NAIR MADHAVAN G (US) | 1991-07-25 | — | — | WO | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| EP-0086680-B1 | STRONG ANTI-ASTHENIC COMPOSITIONS CONTAINING A DOUBLE SALT OF ASCORBIC ACID AND AMINO-DIACIDS | LABORATOIRES MAYOLY SPINDLER (FR) | 1985-12-18 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12378328-B2 | Biohybrid peptidoglycan oligomers | NOD2, DDOST, CD14 | USP2 3361/4885SLCO1B1 796/4885SMN1; SMN2 4384/4885 |
| US-20220213232-A1 | BIOHYBRID PEPTIDOGLYCAN OLIGOMERS | NOD2, DDOST, CD14 | USP2 3361/4885SLCO1B1 796/4885SMN1; SMN2 4384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.